Allon Therapeutics Inc NPCUF

Healthcare Biotechnology

Allon Therapeutics, Inc. is a Canada-based Company, which develops treatments for neurodegenerative diseases. The Company is engaged in pre-clinical and clinical development of proprietary neuroprotective compounds which may be applied for the potential treatment of Alzheimer's Disease, Parkinson's Disease, senile dementia, glaucoma, traumatic head injury, neuronal damage due to stroke and other conditions involving neurodegeneration. The Company's drug, davunetide, is proceeding in a pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under a Special Protocol Assessment (SPA) with the Food and Drug Administration (FDA).

GREY:NPCUF - Post by User

Allon Therapeutics Inc

Bullboard Posts

Comment by stitch1956on Jun 24, 2008 12:17am

416 Views

Post# 15220271

RE: Blid sided

I think this was a smart move. Too often have I seen small companies try to avoid share issuance only to have to do it at a much lower price under stress. Yes they could have waited for more results, but this puts them in a good bargaining position when looking for a pharma partner.

Bullboard Posts

Mullen Group's Robust Case for Value, Part 1: Less-than-Truckload